Cochlear
$125.39Change from previous close: −3.80%Absolute change: −$4.95
Valuation
Data as of October 3, 2026
Valuation multiples
- Market cap
- $8.2B
- Enterprise value
- $8.23B
- P/E (trailing 12 months)
- 55.7
- Forward P/E
- 21.8
- PEG
- 3.08
- Price/book
- 4.71
- Price/sales
- 3.49
- EV/EBITDA
- 17.1
- EV/revenue
- 3.50
Profitability and growth
- Gross margin
- 70.7%
- Operating margin
- 14.3%
- Net margin
- 6.3%
- ROE
- 8.0%
- ROA
- 9.7%
- Revenue growth (year over year)
- 0.8%
Financial health
- Total cash
- $187.7M
- Total debt
- $212.7M
- Debt/equity
- 0.12
- Current ratio
- 2.15
- Quick ratio
- 1.24
Dividends
- Annual dividend per share
- $2.60
- Dividend yield
- 2.1%
- Payout ratio
- 190.9%
- Ex-dividend date
- September 21, 2026
Analysts and estimates
- Average price target
- $137.09
- Median price target
- $138.21
- High price target
- $165.00
- Low price target
- $110.00
- Analysts with a price target
- 16
- Consensus
- Hold
- Forward EPS
- $5.76
- EPS estimate, current year
- $5.19
Shares and trading
- Beta
- 0.27
- Average volume
- 558.79K
- Shares outstanding
- 65.4M
- Float
- 65.14M
- Institutional ownership
- 62.7%
- Insider ownership
- 0.6%